<!DOCTYPE html>

<html>
  <head>
    <title>BCNscreening</title>
    <meta charset="utf-8" />
    <meta
      name="viewport"
      content="width=device-width, initial-scale=1, user-scalable=no"
    />
    <link rel="stylesheet" href="../assets/css/main.css" />
  </head>
  <body class="is-preload">
    <div id="page-wrapper">
      <!-- Wrapper -->
      <div class="wrapper">
        <div class="inner">
          <!-- Header -->
          <header id="header">
            <span class="miga"
              ><a href="index.html"
                ><span class="depan">MÓDULO 4C</span>&nbsp;</a
              ><span
                ><a href="M4Cbiblio.html"
                  ><i class="arrow right"></i>&nbsp;&nbsp;<span class="depan1"
                    >Bibliografía</span
                  ></a
                ></span
              ></span
            >
            <nav>
              <ul>
                <li><a href="#menu"></a></li>
              </ul>
            </nav>
          </header>

          <!-- Nav -->

          <nav id="menu">
            <h4>ÍNDICE</h4>
            <ul class="links">
              <li><a href="M4C1_1.html">&nbsp;Unidad 1</a></li>
              <li><a href="M4C2_1.html">&nbsp;Unidad 2</a></li>
              <li><a href="M4C3_1.html">&nbsp;Unidad 3</a></li>
            </ul>
            <h4>RECURSOS</h4>
            <ul class="links">
              <li><a href="M4Cbiblio.html">&nbsp;Bibliografía</a></li>
              <li><a href="M4Cglossary.html">&nbsp;Glosario</a></li>
              <li><a href="docs/PDF_04C.pdf" target="_blank">&nbsp;Contenido en PDF</a></li>
             
            </ul>
          </nav>
          <!-- Summary -->
          <section class="main">
            <header class="major">
              <h1>BIBLIOGRAFÍA</h1>
             
            </header>
          
            <ol class="alt">
              <li>Solomon D, Davey D, Kurman R, Moriarty A, O’Connor D, Prey M, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002;287:2114-9.

              </li><li>Feldman S, Goodman A, Peipert J. Screening for cervical cancer in resource-rich settings [Internet]. 2017; Disponible <a
                href="https://www.uptodate.com/contents/screening-for-cervical-cancer-in-resource-rich-settings"
                class=""
                target="_blank"
                >aquí <span class="icon solid fa-external-link-alt"></span
              ></a>.
                
            </li><li>NHS Cervical screening: programme and colposcopy management [Internet]. GOV.UK2016 [2021 marzo 23]; Disponible <a
              href="https://www.gov.uk/government/publications/cervical-screening-programme-and-colposcopy-management"
              class=""
              target="_blank"
              >aquí <span class="icon solid fa-external-link-alt"></span
            ></a>.
                
            </li><li>Torne A, Del Pino M, Andia D, Castro M, de la Fuente J, Hernandez JJ, et al. Asociación Española de Patología Cervical y Colposcopia. AEPCC-Guías: GUÍA DE COLPOSCOPIA. ESTÁNDARES DE CALIDAD. [Internet]. 2018; Disponible <a
              href="http://www.aepcc.org/wp-content/uploads/2019/01/AEPCC_revista10-colposcopia-web.pdf"
              class=""
              target="_blank"
              >aquí <span class="icon solid fa-external-link-alt"></span
            ></a>.
                
            </li><li>Perkins RB, Guido RS, Castle PE, Chelmow D, Einstein MH, Garcia F, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. J Low Genit Tract Dis 2020;24:102-31.
                
            </li><li>Cheung LC, Egemen D, Chen X, Katki HA, Demarco M, Wiser AL, et al. 2019 ASCCP Risk-Based Management Consensus Guidelines: Methods for Risk Estimation, Recommended Management, and Validation. J Low Genit Tract Dis 2020;24:90-101.
                
            </li><li>Egemen D, Cheung LC, Chen X, Demarco M, Perkins RB, Kinney W, et al. Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis 2020;24:132-43.
                
            </li><li>Torné A, del Pino M, Cusidó M, Alameda F, Andia D, Castellsagué X, et al. AEPCC-Guía: Prevención del cáncer de cuello de útero 2014. Publicaciones AEPCC 2015;1-55.
                
            </li><li>ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003;188:1383-92.
                
            </li><li>Fleury AC, Birsner ML, Fader AN. Management of the abnormal Papanicolaou smear and colposcopy in pregnancy: an evidenced-based review. Minerva Ginecol 2012;64:137-48.
                
            </li><li>Piccoli R, Mandato VD, Lavitola G, Acunzo G, Bifulco G, Tommaselli GA, et al. Atypical squamous cells and low squamous intraepithelial lesions in postmenopausal women: implications for management. Eur J Obstet Gynecol Reprod Biol 2008;140:269-74.
                
            </li><li>Demarco M, Lorey TS, Fetterman B, Cheung LC, Guido RS, Wentzensen N, et al. Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines. J Low Genit Tract Dis 2017;21:261-7.
                
            </li><li>Nayar R, Chhieng DC, Crothers B, Darragh TM, Davey DD, Eisenhut C, et al. Moving forward-the 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors and beyond: implications and suggestions for laboratories. J Am Soc Cytopathol 2020;9:291-303.
                
            </li><li>Sideri M, Igidbashian S, Boveri S, Radice D, Casadio C, Spolti N, et al. Age distribution of HPV genotypes in cervical intraepithelial neoplasia. Gynecol Oncol 2011;121:510-3.
                
            </li><li>Demarco M, Egemen D, Raine-Bennett TR, Cheung LC, Befano B, Poitras NE, et al. A Study of Partial Human Papillomavirus Genotyping in Support of the 2019 ASCCP Risk-Based Management Consensus Guidelines. J Low Genit Tract Dis 2020;24:144-7.
                
            </li><li>Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, et al. Five-year risks of CIN 3+ and cervical cancer among women with HPV testing of ASC-US Pap results. J Low Genit Tract Dis 2013;17:S36-42.
                
            </li><li>McCredie MRE, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, et al. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008;9:425-34.
                
            </li><li>Kumar N, Gupta R, Gupta S. Glandular cell abnormalities in cervical cytology: What has changed in this decade and what has not? European Journal of Obstetrics and Gynecology and Reproductive Biology 2019;240:68-73.
                
            </li><li>Cox JT, Castle PE, Behrens CM, Sharma A, Wright TC, Cuzick J, et al. Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study. Am J Obstet Gynecol 2013;208:184.e1-184.e11.
                
            </li><li>Gage JC, Duggan MA, Nation JG, Gao S, Castle PE. Comparative risk of high-grade histopathology diagnosis after a CIN 1 finding in endocervical curettage versus cervical biopsy. J Low Genit Tract Dis 2013;17:137-41.
                
            </li><li>Petersen S, Belnap C, Larsen WI, Farley J. Grading of squamous dysplasia in endocervical curettage specimens: The case for conservative management of mild endocervical dysplasia. J Reprod Med 2007;52:917-21.
                
            </li><li>Munmany M, Marimon L, Cardona M, Nonell R, Juiz M, Astudillo R, et al. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen. BJOG 2017;124:495-502.
                
            </li><li>Munmany M, Torne A, Nonell R, Barnadas E, Luqui N, Del Pino M. Colposcopy Evaluation at the Time of Loop Electrosurgical Excision Procedure May Avoid Unnecessary Treatment. J Low Genit Tract Dis. 2018;22:367-374.
                
            </li><li>Rodríguez-Manfredi Á, van Baars R, Quint WGV, Sanchez MJ, Torné A, Ordi J, et al. HPV genotyping among women treated for high-grade cervical intraepithelial neoplasia with no lesion in the conization specimen. Int J Gynaecol Obstet 2015;129:109-13.
                
            </li><li>Rodriguez-Manfredi A, Alonso I, Pino M del, Fusté P, Torné A, Ordi J. Predictors of absence of cervical intraepithelial neoplasia in the conization specimen. Gynecologic Oncology 2013;128:271-6.
                
            </li><li>Kyrgiou M, Tsoumpou I, Vrekoussis T, Martin-Hirsch P, Arbyn M, Prendiville W, et al. The up-to-date evidence on colposcopy practice and treatment of cervical intraepithelial neoplasia: the Cochrane colposcopy & cervical cytopathology collaborative group (C5 group) approach. Cancer Treat Rev 2006;32:516-23.
                
            </li><li>Tainio K, Athanasiou A, Tikkinen KAO, Aaltonen R, Cárdenas J, Hernándes null, et al. Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis. BMJ 2018;360:k499.
                
            </li><li>Joura EA, Garland SM, Paavonen J, Ferris DG, Perez G, Ault KA, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012;344:e1401.
                
            </li><li>ElMasri WM, Walts AE, Chiang A, Walsh CS. Predictors of invasive adenocarcinoma after conization for cervical adenocarcinoma in situ. Gynecol Oncol 2012;125:589-93.
                
            </li><li>Costa S, Venturoli S, Negri G, Sideri M, Preti M, Pesaresi M, et al. Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 cases. Gynecol Oncol 2012;124:490-5.
                
            </li><li>Melnikow J, McGahan C, Sawaya GF, Ehlen T, Coldman A. Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study. J Natl Cancer Inst 2009;101:721-8.
                
            </li><li>Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cervical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:2048-55.
                
            </li><li>Sand FL, Frederiksen K, Munk C, Jensen SM, Kjær SK. Long-term risk of cervical cancer following conization of cervical intraepithelial neoplasia grade 3—A Danish nationwide cohort study. International Journal of Cancer 2018;142:1759-66.
                
            </li><li>Rebolj M, Helmerhorst T, Habbema D, Looman C, Boer R, Van Rosmalen J, et al. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: Population based cohort study. BMJ (Online) 2012;345:1-11.
                
            </li><li>Lapaquette TK, Dinh T V., Hannigan E V., Doherty MG, Yandell RB, Buchanan VS. Management of patients with positive margins after cervical conization. Obstetrics and Gynecology 1993;82:440-3.
                
            </li><li>Kietpeerakool C, Srisomboon J, Ratchusiri K. Clinicopathologic predictors of incomplete excision after loop electrosurgical excision for cervical preneoplasia. Asian Pacific Journal of Cancer Prevention 2005;6:481-4.
                
            </li><li>Prendiville W, Sankaranarayanan R. Colposcopy and Treatment of Cervical Precancer. IARC Technical Publications; 45; 2017.
                
            </li><li>Kocken M, Helmerhorst TJM, Berkhof J, Louwers JA, Nobbenhuis MAE, Bais AG, et al. Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: A long-term multi-cohort study. The Lancet Oncology 2011;12:441-50.
                
            </li><li>Torné A, Fusté P, Rodríguez-Carunchio L, Alonso I, Del Pino M, Nonell R, et al. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: A pilot study. BJOG: An International Journal of Obstetrics and Gynaecology 2013;120:392-9.
                
            </li><li>Alonso I, Torne A, Puig-Tintore LM, Esteve R, Quinto L, Campo E, et al. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3. Gynecologic Oncology 2006;103:631-6.
                
            </li><li>Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: Triage of minor cervical lesions, follow-up of women treated for high-grade CIN: An update of pooled evidence. En: Gynecologic Oncology. 2005.
                
            </li><li>Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, et al. Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma. ecancermedicalscience2015;9.
                
            </li><li>Arbyn M, Redman CWE, Verdoodt F, Kyrgiou M, Tzafetas M, Ghaem-Maghami S, et al. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis. The Lancet Oncology 2017;18:1665-79.
                
            </li><li>PublicHealthEngland. NHS Public Health Functions Agreement 2019-20. NHS Public Health Functions Agreement 2019-20 2019;13.
                
            </li><li>IARC Working Group on the Evaluation of Cancer Preventive Strategies. IARC Handbooks of Cancer Prevention. Cervix Cancer Screening. Lyon, france: IARC Press; 2005.
                
            </li><li>Ghelardi A, Parazzini F, Martella F, Pieralli A, Bay P, Tonetti A, et al. SPERANZA project: HPV vaccination after treatment for CIN2+. Gynecologic Oncology 2018;151:229-34.
                
            </li><li>Velentzis LS, Brotherton JML, Canfell K. Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions. Climacteric2019;
                
            </li><li>del Pino M, Martí C, Torras I, Henere C, Munmany M, Marimon L, et al. HPV vaccination as adjuvant to conization in women with cervical intraepithelial neoplasia: A study under real-life conditions. Vaccines 2020;8.
                
            </li><li>Garland SM, Paavonen J, Jaisamrarn U, Naud P, Salmerón J, Chow SN, et al. Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post-hoc analysis from a randomized controlled trial. International Journal of Cancer 2016;139:2812-26.
                
            </li><li>Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2-3)? Gynecol Oncol 2013;130:264-8.
                
            </li><li>Martínez-Gómez X, Curran A, Campins M, Alemany L, Rodrigo-Pendás JÁ, Borruel N, et al. Multidisciplinary, evidence-based consensus guidelines for human papillomavirus (HPV) vaccination in highrisk populations, Spain, 2016. Eurosurveillance 2019;24:1-14.</li>
                
                
                
                
          </section>
          <!-- Section -->
          <section class="main">
          
            <header class="major">
              <h2>ÍNDICE:</h2>
            </header>

            <div class="featuresA">
              <section>
                <a href="M4C1_1.html"
                  ><span class="icon solid fa-file-invoice major accent4"></span
                ></a>
                <h3><a href="M4C1_1.html" class="button">UNIDAD 1</a></h3>
                <a href="M4C1_1.html"
                  ><h4>Manejo clínico</h4>
                  <p>Manejo clínico de los resultados de la citología</p></a
                >
              </section>
              <section>
                <a href="M4C2_1.html"
                  ><span
                    class="icon solid fa-file-medical-alt major accent4"
                  ></span
                ></a>
                <h3><a href="M4C2_1.html" class="button">UNIDAD 2</a></h3>
                <a href="M4C2_1.html"
                  ><h4>Manejo clínico</h4>
                  <p>Manejo clínico de los resultados histológicos</p></a
                >
              </section>
              <section>
                <a href="M4C3_1.html"
                  ><span class="icon solid fa-file-medical major accent5"></span
                ></a>
                <h3><a href="M4C3_1.html" class="button">UNIDAD 3</a></h3>
                <a href="M4C3_1.html"
                  ><h4>Seguimiento después del diagnóstico</h4>
                  <p>Seguimiento</p></a
                >
              </section>
            </div>

            <hr />
            <header class="major">
              <h2>RECURSOS</h2>
            </header>
            <div class="featuresA">
              <section>
                <a href="M4Cbiblio.html"
                  ><span class="icon solid fa-book major accent3"></span
                ></a>
                <h3>
                  <a href="M4Cbiblio.html" class="button">Bibliografía</a>
                </h3>
              </section>
              <section>
                <a href="M4Cglossary.html"
                  ><span class="icon solid fa-font major accent3"></span
                ></a>
                <h3><a href="M4Cglossary.html" class="button">Glosario</a></h3>
              </section>
              <section>
                <a href="docs/PDF_04C.pdf" target="_blank"
                  ><span class="icon solid fa-file major accent3"></span
                ></a>
                <h3>
                  <a href="docs/PDF_04C.pdf" target="_blank" class="button"
                    >PDF</a
                  >
                </h3>
              </section>
            </div>
          </section>
        </div>
      </div>




      <!-- Wrapper -->
      <div class="wrapper">
        <div class="inner">
          <!-- Footer -->
          <footer id="footer">
            <div class="image">
              <a href="https://www.e-oncologia.org/" target="_blank"
                ><img src="../images/logos.png" alt="" data-position=""
              /></a>
            </div>
          </footer>
        </div>
      </div>
    </div>

    <!-- Scripts -->
    <script src="../assets/js/jquery.min.js"></script>
    <script src="../assets/js/browser.min.js"></script>
    <script src="../assets/js/breakpoints.min.js"></script>
    <script src="../assets/js/util.js"></script>
    <script src="../assets/js/main.js"></script>
  </body>
</html>
